Letter to the Editor: HCC surveillance in cirrhosis patients: Is the real-world situation even worse than reported? Hepatology (Baltimore, Md.) Huang, D. Q., Yeo, Y. H., Nguyen, M. H. 2021


We read with interest the recent systematic review and meta-analysis by Wolf and colleagues, which reported a pooled estimate for hepatocellular carcinoma (HCC) surveillance of 24.0% for patients with cirrhosis (1). We applaud the authors for performing this comprehensive study on a topic that is not only relevant clinically but also timely, especially with the increasing burden of cirrhosis in recent decades.

View details for DOI 10.1002/hep.31760

View details for PubMedID 33617661